Onshoring Drug Manufacturing and TRIPS Waiver Part II
Subscribe to OnAir with Akin Gump via iTunes, SoundCloud, YouTube, Spotify and Google Play.
In this new episode of OnAir: Health Care, Akin Gump health care senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome Akin Gump public law and policy partner Clete Willems and Centrient Pharmaceuticals chief legal and compliance officer Jim DeYonker.
Among the topics covered:
- The TRIPS waiver and vaccines.
- Global supply chains.
- Onshoring drug manufacturing.
- Enforcing IP outside the U.S..
To learn more, search for “health care” via the menu at top right.
Speakers
© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.